Notice of Effectiveness · EFFECT
MapLight Therapeutics, Inc.
MPLTNASDAQEQUITYCurrent
Notice of Effectiveness
Structured filing — EFFECT
primary_doc.xml
Notice details
- Submission type
- EFFECT
- Act
- 33
Effectiveness
- Effective date
- 2026-11-17
- Submission type
- POS AM
- Related accession
- 0001193125-26-462287
Registrant 1
- Registrant
- MapLight Therapeutics, Inc.
- Registrant CIK
- 0001770069
- File number
- 333-298837
Company context
MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. The Company was founded by globally recognized leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The Company’s discovery platform holds the potential to fill this void by identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation.